Anteris Technologies Global Corp. (NASDAQ: AVR) Stock Competitors & Peer Comparison
See AVR's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for AVR and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| AVR | $8.93 | +0.68% | 868.3M | -4.00 | -$2.23 | N/A |
| ABT | $111.27 | +0.32% | 192.6B | 21.36 | $5.21 | +2.23% |
| BSX-PA | $122.18 | +2.37% | 175.4B | 230.53 | $0.53 | N/A |
| SYK | $341.09 | -1.76% | 130.8B | 25.47 | $13.39 | +1.02% |
| MDT | $90.58 | -0.20% | 116B | 16.38 | $5.53 | +3.14% |
| BSX | $51.69 | +0.53% | 76.9B | 16.68 | $3.10 | N/A |
| EW | $92.56 | -0.53% | 53.3B | 34.29 | $2.70 | N/A |
| DXCM | $91.48 | +0.75% | 34.5B | 39.26 | $2.33 | N/A |
| RMD | $226.74 | +0.33% | 32.9B | 21.06 | $10.77 | +1.05% |
| PHG | $27.38 | +2.16% | 26.8B | 15.64 | $1.75 | +3.62% |
Stock Comparison
Abbott Laboratories (NYSE: ABT)
AVR vs ABT Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, ABT has a market cap of 192.6B. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while ABT trades at $111.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas ABT's P/E ratio is 21.36. In terms of profitability, AVR's ROE is -0.78%, compared to ABT's ROE of +0.11%. Regarding short-term risk, AVR is more volatile compared to ABT. This indicates higher risk in terms of short-term price fluctuations for AVR.Check ABT's competition here
Boston Scientific Corporation (NYSE: BSX-PA)
AVR vs BSX-PA Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while BSX-PA trades at $122.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, AVR's ROE is -0.78%, compared to BSX-PA's ROE of +0.15%. Regarding short-term risk, AVR is more volatile compared to BSX-PA. This indicates higher risk in terms of short-term price fluctuations for AVR.Check BSX-PA's competition here
Stryker Corporation (NYSE: SYK)
AVR vs SYK Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, SYK has a market cap of 130.8B. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while SYK trades at $341.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas SYK's P/E ratio is 25.47. In terms of profitability, AVR's ROE is -0.78%, compared to SYK's ROE of +0.16%. Regarding short-term risk, AVR is more volatile compared to SYK. This indicates higher risk in terms of short-term price fluctuations for AVR.Check SYK's competition here
Medtronic plc (NYSE: MDT)
AVR vs MDT Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, MDT has a market cap of 116B. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while MDT trades at $90.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas MDT's P/E ratio is 16.38. In terms of profitability, AVR's ROE is -0.78%, compared to MDT's ROE of +0.10%. Regarding short-term risk, AVR is more volatile compared to MDT. This indicates higher risk in terms of short-term price fluctuations for AVR.Check MDT's competition here
Boston Scientific Corporation (NYSE: BSX)
AVR vs BSX Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, BSX has a market cap of 76.9B. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while BSX trades at $51.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas BSX's P/E ratio is 16.68. In terms of profitability, AVR's ROE is -0.78%, compared to BSX's ROE of +0.15%. Regarding short-term risk, AVR is more volatile compared to BSX. This indicates higher risk in terms of short-term price fluctuations for AVR.Check BSX's competition here
Edwards Lifesciences Corporation (NYSE: EW)
AVR vs EW Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, EW has a market cap of 53.3B. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while EW trades at $92.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas EW's P/E ratio is 34.29. In terms of profitability, AVR's ROE is -0.78%, compared to EW's ROE of +0.10%. Regarding short-term risk, AVR is more volatile compared to EW. This indicates higher risk in terms of short-term price fluctuations for AVR.Check EW's competition here
DexCom, Inc. (NASDAQ: DXCM)
AVR vs DXCM Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, DXCM has a market cap of 34.5B. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while DXCM trades at $91.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas DXCM's P/E ratio is 39.26. In terms of profitability, AVR's ROE is -0.78%, compared to DXCM's ROE of +0.36%. Regarding short-term risk, AVR is more volatile compared to DXCM. This indicates higher risk in terms of short-term price fluctuations for AVR.Check DXCM's competition here
ResMed Inc. (NYSE: RMD)
AVR vs RMD Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, RMD has a market cap of 32.9B. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while RMD trades at $226.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas RMD's P/E ratio is 21.06. In terms of profitability, AVR's ROE is -0.78%, compared to RMD's ROE of +0.24%. Regarding short-term risk, AVR is more volatile compared to RMD. This indicates higher risk in terms of short-term price fluctuations for AVR.Check RMD's competition here
Koninklijke Philips N.V. (NYSE: PHG)
AVR vs PHG Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, PHG has a market cap of 26.8B. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while PHG trades at $27.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas PHG's P/E ratio is 15.64. In terms of profitability, AVR's ROE is -0.78%, compared to PHG's ROE of +0.10%. Regarding short-term risk, AVR is more volatile compared to PHG. This indicates higher risk in terms of short-term price fluctuations for AVR.Check PHG's competition here
Zimmer Biomet Holdings, Inc. (NYSE: ZBH)
AVR vs ZBH Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, ZBH has a market cap of 19.3B. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while ZBH trades at $99.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas ZBH's P/E ratio is 11.74. In terms of profitability, AVR's ROE is -0.78%, compared to ZBH's ROE of +0.06%. Regarding short-term risk, AVR is more volatile compared to ZBH. This indicates higher risk in terms of short-term price fluctuations for AVR.Check ZBH's competition here
Abiomed, Inc. (NASDAQ: ABMD)
AVR vs ABMD Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while ABMD trades at $381.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas ABMD's P/E ratio is 65.36. In terms of profitability, AVR's ROE is -0.78%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, AVR is more volatile compared to ABMD. This indicates higher risk in terms of short-term price fluctuations for AVR.Check ABMD's competition here
Penumbra, Inc. (NYSE: PEN)
AVR vs PEN Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, PEN has a market cap of 12.9B. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while PEN trades at $326.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas PEN's P/E ratio is 85.36. In terms of profitability, AVR's ROE is -0.78%, compared to PEN's ROE of +0.11%. Regarding short-term risk, AVR is more volatile compared to PEN. This indicates higher risk in terms of short-term price fluctuations for AVR.Check PEN's competition here
Smith & Nephew plc (NYSE: SNN)
AVR vs SNN Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, SNN has a market cap of 12.7B. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while SNN trades at $30.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas SNN's P/E ratio is 14.17. In terms of profitability, AVR's ROE is -0.78%, compared to SNN's ROE of +0.12%. Regarding short-term risk, AVR is more volatile compared to SNN. This indicates higher risk in terms of short-term price fluctuations for AVR.Check SNN's competition here
Align Technology, Inc. (NASDAQ: ALGN)
AVR vs ALGN Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, ALGN has a market cap of 12.6B. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while ALGN trades at $176.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas ALGN's P/E ratio is 16.06. In terms of profitability, AVR's ROE is -0.78%, compared to ALGN's ROE of +0.14%. Regarding short-term risk, AVR is more volatile compared to ALGN. This indicates higher risk in terms of short-term price fluctuations for AVR.Check ALGN's competition here
ShockWave Medical, Inc. (NASDAQ: SWAV)
AVR vs SWAV Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, SWAV has a market cap of 12.6B. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while SWAV trades at $334.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas SWAV's P/E ratio is 78.76. In terms of profitability, AVR's ROE is -0.78%, compared to SWAV's ROE of +0.25%. Regarding short-term risk, AVR is more volatile compared to SWAV. This indicates higher risk in terms of short-term price fluctuations for AVR.Check SWAV's competition here
Globus Medical, Inc. (NYSE: GMED)
AVR vs GMED Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, GMED has a market cap of 11.6B. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while GMED trades at $85.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas GMED's P/E ratio is 19.36. In terms of profitability, AVR's ROE is -0.78%, compared to GMED's ROE of +0.12%. Regarding short-term risk, AVR is more volatile compared to GMED. This indicates higher risk in terms of short-term price fluctuations for AVR.Check GMED's competition here
Glaukos Corporation (NYSE: GKOS)
AVR vs GKOS Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, GKOS has a market cap of 11.2B. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while GKOS trades at $189.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas GKOS's P/E ratio is -220.30. In terms of profitability, AVR's ROE is -0.78%, compared to GKOS's ROE of -0.27%. Regarding short-term risk, AVR is more volatile compared to GKOS. This indicates higher risk in terms of short-term price fluctuations for AVR.Check GKOS's competition here
Insulet Corp. (NASDAQ: PODD)
AVR vs PODD Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, PODD has a market cap of 10.1B. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while PODD trades at $146.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas PODD's P/E ratio is 24.95. In terms of profitability, AVR's ROE is -0.78%, compared to PODD's ROE of +0.27%. Regarding short-term risk, AVR is more volatile compared to PODD. This indicates higher risk in terms of short-term price fluctuations for AVR.Check PODD's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO)
AVR vs BIO Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, BIO has a market cap of 9.7B. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while BIO trades at $361.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas BIO's P/E ratio is 38.93. In terms of profitability, AVR's ROE is -0.78%, compared to BIO's ROE of +0.03%. Regarding short-term risk, AVR is less volatile compared to BIO. This indicates lower risk in terms of short-term price fluctuations for AVR.Check BIO's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO-B)
AVR vs BIO-B Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, BIO-B has a market cap of 9.5B. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while BIO-B trades at $348.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas BIO-B's P/E ratio is 103.33. In terms of profitability, AVR's ROE is -0.78%, compared to BIO-B's ROE of +0.03%. Regarding short-term risk, AVR is more volatile compared to BIO-B. This indicates higher risk in terms of short-term price fluctuations for AVR.Check BIO-B's competition here
Masimo Corporation (NASDAQ: MASI)
AVR vs MASI Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, MASI has a market cap of 9.4B. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while MASI trades at $179.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas MASI's P/E ratio is 44.43. In terms of profitability, AVR's ROE is -0.78%, compared to MASI's ROE of +0.09%. Regarding short-term risk, AVR is more volatile compared to MASI. This indicates higher risk in terms of short-term price fluctuations for AVR.Check MASI's competition here
Bruker Corporation (NASDAQ: BRKR)
AVR vs BRKR Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, BRKR has a market cap of 8.8B. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while BRKR trades at $57.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas BRKR's P/E ratio is 29.11. In terms of profitability, AVR's ROE is -0.78%, compared to BRKR's ROE of -0.03%. Regarding short-term risk, AVR is less volatile compared to BRKR. This indicates lower risk in terms of short-term price fluctuations for AVR.Check BRKR's competition here
Inari Medical, Inc. (NASDAQ: NARI)
AVR vs NARI Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while NARI trades at $79.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas NARI's P/E ratio is -59.24. In terms of profitability, AVR's ROE is -0.78%, compared to NARI's ROE of -0.00%. Regarding short-term risk, AVR is more volatile compared to NARI. This indicates higher risk in terms of short-term price fluctuations for AVR.Check NARI's competition here
LivaNova PLC (NASDAQ: LIVN)
AVR vs LIVN Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, LIVN has a market cap of 4.4B. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while LIVN trades at $82.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas LIVN's P/E ratio is 19.19. In terms of profitability, AVR's ROE is -0.78%, compared to LIVN's ROE of +0.15%. Regarding short-term risk, AVR is more volatile compared to LIVN. This indicates higher risk in terms of short-term price fluctuations for AVR.Check LIVN's competition here
Integer Holdings Corporation (NYSE: ITGR)
AVR vs ITGR Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, ITGR has a market cap of 4.2B. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while ITGR trades at $125.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas ITGR's P/E ratio is 19.69. In terms of profitability, AVR's ROE is -0.78%, compared to ITGR's ROE of +0.07%. Regarding short-term risk, AVR is more volatile compared to ITGR. This indicates higher risk in terms of short-term price fluctuations for AVR.Check ITGR's competition here
Haemonetics Corporation (NYSE: HAE)
AVR vs HAE Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, HAE has a market cap of 4.1B. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while HAE trades at $90.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas HAE's P/E ratio is 18.06. In terms of profitability, AVR's ROE is -0.78%, compared to HAE's ROE of +0.11%. Regarding short-term risk, AVR is more volatile compared to HAE. This indicates higher risk in terms of short-term price fluctuations for AVR.Check HAE's competition here
iRhythm Technologies, Inc. (NASDAQ: IRTC)
AVR vs IRTC Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, IRTC has a market cap of 4B. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while IRTC trades at $123.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas IRTC's P/E ratio is -192.44. In terms of profitability, AVR's ROE is -0.78%, compared to IRTC's ROE of -0.09%. Regarding short-term risk, AVR is more volatile compared to IRTC. This indicates higher risk in terms of short-term price fluctuations for AVR.Check IRTC's competition here
Axonics, Inc. (NASDAQ: AXNX)
AVR vs AXNX Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, AXNX has a market cap of 3.6B. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while AXNX trades at $70.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas AXNX's P/E ratio is -709.80. In terms of profitability, AVR's ROE is -0.78%, compared to AXNX's ROE of -0.01%. Regarding short-term risk, AVR is more volatile compared to AXNX. This indicates higher risk in terms of short-term price fluctuations for AVR.Check AXNX's competition here
TransMedics Group, Inc. (NASDAQ: TMDX)
AVR vs TMDX Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, TMDX has a market cap of 3.1B. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while TMDX trades at $89.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas TMDX's P/E ratio is 45.50. In terms of profitability, AVR's ROE is -0.78%, compared to TMDX's ROE of +0.33%. Regarding short-term risk, AVR is less volatile compared to TMDX. This indicates lower risk in terms of short-term price fluctuations for AVR.Check TMDX's competition here
AxoGen, Inc. (NASDAQ: AXGN)
AVR vs AXGN Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, AXGN has a market cap of 2.6B. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while AXGN trades at $48.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas AXGN's P/E ratio is 126.45. In terms of profitability, AVR's ROE is -0.78%, compared to AXGN's ROE of -0.18%. Regarding short-term risk, AVR is less volatile compared to AXGN. This indicates lower risk in terms of short-term price fluctuations for AVR.Check AXGN's competition here
UFP Technologies, Inc. (NASDAQ: UFPT)
AVR vs UFPT Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, UFPT has a market cap of 2.5B. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while UFPT trades at $319.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas UFPT's P/E ratio is 32.67. In terms of profitability, AVR's ROE is -0.78%, compared to UFPT's ROE of +0.17%. Regarding short-term risk, AVR is less volatile compared to UFPT. This indicates lower risk in terms of short-term price fluctuations for AVR.Check UFPT's competition here
Butterfly Network, Inc. (NYSE: BFLY)
AVR vs BFLY Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, BFLY has a market cap of 2.4B. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while BFLY trades at $8.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas BFLY's P/E ratio is -36.79. In terms of profitability, AVR's ROE is -0.78%, compared to BFLY's ROE of -0.38%. Regarding short-term risk, AVR is less volatile compared to BFLY. This indicates lower risk in terms of short-term price fluctuations for AVR.Check BFLY's competition here
Establishment Labs Holdings Inc. (NASDAQ: ESTA)
AVR vs ESTA Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, ESTA has a market cap of 2.2B. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while ESTA trades at $75.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas ESTA's P/E ratio is -59.99. In terms of profitability, AVR's ROE is -0.78%, compared to ESTA's ROE of -2.04%. Regarding short-term risk, AVR is less volatile compared to ESTA. This indicates lower risk in terms of short-term price fluctuations for AVR.Check ESTA's competition here
NuVasive, Inc. (NASDAQ: NUVA)
AVR vs NUVA Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while NUVA trades at $39.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas NUVA's P/E ratio is 75.00. In terms of profitability, AVR's ROE is -0.78%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, AVR is less volatile compared to NUVA. This indicates lower risk in terms of short-term price fluctuations for AVR.Check NUVA's competition here
Novocure Ltd (NASDAQ: NVCR)
AVR vs NVCR Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, NVCR has a market cap of 2B. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while NVCR trades at $17.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas NVCR's P/E ratio is -11.36. In terms of profitability, AVR's ROE is -0.78%, compared to NVCR's ROE of -0.44%. Regarding short-term risk, AVR is less volatile compared to NVCR. This indicates lower risk in terms of short-term price fluctuations for AVR.Check NVCR's competition here
Inspire Medical Systems, Inc. (NYSE: INSP)
AVR vs INSP Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, INSP has a market cap of 1.7B. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while INSP trades at $58.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas INSP's P/E ratio is 25.62. In terms of profitability, AVR's ROE is -0.78%, compared to INSP's ROE of +0.18%. Regarding short-term risk, AVR is more volatile compared to INSP. This indicates higher risk in terms of short-term price fluctuations for AVR.Check INSP's competition here
Tandem Diabetes Care, Inc. (NASDAQ: TNDM)
AVR vs TNDM Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, TNDM has a market cap of 1.6B. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while TNDM trades at $23.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas TNDM's P/E ratio is -21.03. In terms of profitability, AVR's ROE is -0.78%, compared to TNDM's ROE of -0.46%. Regarding short-term risk, AVR is more volatile compared to TNDM. This indicates higher risk in terms of short-term price fluctuations for AVR.Check TNDM's competition here
Alphatec Holdings, Inc. (NASDAQ: ATEC)
AVR vs ATEC Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, ATEC has a market cap of 1.5B. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while ATEC trades at $9.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas ATEC's P/E ratio is -162.50. In terms of profitability, AVR's ROE is -0.78%, compared to ATEC's ROE of -8.19%. Regarding short-term risk, AVR is more volatile compared to ATEC. This indicates higher risk in terms of short-term price fluctuations for AVR.Check ATEC's competition here
CONMED Corporation (NYSE: CNMD)
AVR vs CNMD Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, CNMD has a market cap of 1.5B. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while CNMD trades at $49.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas CNMD's P/E ratio is 10.94. In terms of profitability, AVR's ROE is -0.78%, compared to CNMD's ROE of +0.06%. Regarding short-term risk, AVR is more volatile compared to CNMD. This indicates higher risk in terms of short-term price fluctuations for AVR.Check CNMD's competition here
Enovis Corporation (NYSE: ENOV)
AVR vs ENOV Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, ENOV has a market cap of 1.5B. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while ENOV trades at $25.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas ENOV's P/E ratio is 7.36. In terms of profitability, AVR's ROE is -0.78%, compared to ENOV's ROE of -0.68%. Regarding short-term risk, AVR is less volatile compared to ENOV. This indicates lower risk in terms of short-term price fluctuations for AVR.Check ENOV's competition here
Integra LifeSciences Holdings Corporation (NASDAQ: IART)
AVR vs IART Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, IART has a market cap of 1.4B. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while IART trades at $18.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas IART's P/E ratio is 7.73. In terms of profitability, AVR's ROE is -0.78%, compared to IART's ROE of -0.01%. Regarding short-term risk, AVR is less volatile compared to IART. This indicates lower risk in terms of short-term price fluctuations for AVR.Check IART's competition here
Artivion, Inc. (NYSE: AORT)
AVR vs AORT Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, AORT has a market cap of 1.4B. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while AORT trades at $28.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas AORT's P/E ratio is 47.38. In terms of profitability, AVR's ROE is -0.78%, compared to AORT's ROE of -0.01%. Regarding short-term risk, AVR is more volatile compared to AORT. This indicates higher risk in terms of short-term price fluctuations for AVR.Check AORT's competition here
Heska Corporation (NASDAQ: HSKA)
AVR vs HSKA Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while HSKA trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas HSKA's P/E ratio is -62.49. In terms of profitability, AVR's ROE is -0.78%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, AVR is more volatile compared to HSKA. This indicates higher risk in terms of short-term price fluctuations for AVR.Check HSKA's competition here
PROCEPT BioRobotics Corporation (NASDAQ: PRCT)
AVR vs PRCT Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, PRCT has a market cap of 1.2B. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while PRCT trades at $21.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas PRCT's P/E ratio is -11.31. In terms of profitability, AVR's ROE is -0.78%, compared to PRCT's ROE of -0.31%. Regarding short-term risk, AVR is less volatile compared to PRCT. This indicates lower risk in terms of short-term price fluctuations for AVR.Check PRCT's competition here
Avanos Medical, Inc. (NYSE: AVNS)
AVR vs AVNS Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, AVNS has a market cap of 1.2B. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while AVNS trades at $24.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas AVNS's P/E ratio is 27.77. In terms of profitability, AVR's ROE is -0.78%, compared to AVNS's ROE of -0.09%. Regarding short-term risk, AVR is more volatile compared to AVNS. This indicates higher risk in terms of short-term price fluctuations for AVR.Check AVNS's competition here
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI)
AVR vs LMRI Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, LMRI has a market cap of 1.1B. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while LMRI trades at $12.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas LMRI's P/E ratio is -22.82. In terms of profitability, AVR's ROE is -0.78%, compared to LMRI's ROE of -0.06%. Regarding short-term risk, AVR is less volatile compared to LMRI. This indicates lower risk in terms of short-term price fluctuations for AVR.Check LMRI's competition here
Silk Road Medical, Inc (NASDAQ: SILK)
AVR vs SILK Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while SILK trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas SILK's P/E ratio is -18.96. In terms of profitability, AVR's ROE is -0.78%, compared to SILK's ROE of -0.35%. Regarding short-term risk, AVR is more volatile compared to SILK. This indicates higher risk in terms of short-term price fluctuations for AVR.Check SILK's competition here
IRadimed Corporation (NASDAQ: IRMD)
AVR vs IRMD Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, IRMD has a market cap of 1.1B. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while IRMD trades at $87.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas IRMD's P/E ratio is 43.80. In terms of profitability, AVR's ROE is -0.78%, compared to IRMD's ROE of +0.23%. Regarding short-term risk, AVR is more volatile compared to IRMD. This indicates higher risk in terms of short-term price fluctuations for AVR.Check IRMD's competition here
Paragon 28, Inc. (NYSE: FNA)
AVR vs FNA Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while FNA trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas FNA's P/E ratio is -19.83. In terms of profitability, AVR's ROE is -0.78%, compared to FNA's ROE of -0.35%. Regarding short-term risk, AVR is more volatile compared to FNA. This indicates higher risk in terms of short-term price fluctuations for AVR.Check FNA's competition here
Bioventus Inc. (NASDAQ: BVS)
AVR vs BVS Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, BVS has a market cap of 941M. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while BVS trades at $13.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas BVS's P/E ratio is 18.28. In terms of profitability, AVR's ROE is -0.78%, compared to BVS's ROE of +0.28%. Regarding short-term risk, AVR is more volatile compared to BVS. This indicates higher risk in terms of short-term price fluctuations for AVR.Check BVS's competition here
CeriBell, Inc. (NASDAQ: CBLL)
AVR vs CBLL Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, CBLL has a market cap of 882.2M. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while CBLL trades at $23.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas CBLL's P/E ratio is -14.26. In terms of profitability, AVR's ROE is -0.78%, compared to CBLL's ROE of -0.45%. Regarding short-term risk, AVR is less volatile compared to CBLL. This indicates lower risk in terms of short-term price fluctuations for AVR.Check CBLL's competition here
InMode Ltd. (NASDAQ: INMD)
AVR vs INMD Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, INMD has a market cap of 873.7M. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while INMD trades at $15.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas INMD's P/E ratio is 10.56. In terms of profitability, AVR's ROE is -0.78%, compared to INMD's ROE of +0.12%. Regarding short-term risk, AVR is more volatile compared to INMD. This indicates higher risk in terms of short-term price fluctuations for AVR.Check INMD's competition here
Cardiovascular Systems, Inc. (NASDAQ: CSII)
AVR vs CSII Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, CSII has a market cap of 844M. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while CSII trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas CSII's P/E ratio is -20.83. In terms of profitability, AVR's ROE is -0.78%, compared to CSII's ROE of -0.14%. Regarding short-term risk, AVR is more volatile compared to CSII. This indicates higher risk in terms of short-term price fluctuations for AVR.Check CSII's competition here
SI-BONE, Inc. (NASDAQ: SIBN)
AVR vs SIBN Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, SIBN has a market cap of 840.4M. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while SIBN trades at $18.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas SIBN's P/E ratio is -55.74. In terms of profitability, AVR's ROE is -0.78%, compared to SIBN's ROE of -0.08%. Regarding short-term risk, AVR is more volatile compared to SIBN. This indicates higher risk in terms of short-term price fluctuations for AVR.Check SIBN's competition here
Beta Bionics, Inc. (NASDAQ: BBNX)
AVR vs BBNX Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, BBNX has a market cap of 813.4M. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while BBNX trades at $18.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas BBNX's P/E ratio is -11.97. In terms of profitability, AVR's ROE is -0.78%, compared to BBNX's ROE of -0.26%. Regarding short-term risk, AVR is less volatile compared to BBNX. This indicates lower risk in terms of short-term price fluctuations for AVR.Check BBNX's competition here
Varex Imaging Corporation (NASDAQ: VREX)
AVR vs VREX Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, VREX has a market cap of 778.9M. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while VREX trades at $18.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas VREX's P/E ratio is 19.47. In terms of profitability, AVR's ROE is -0.78%, compared to VREX's ROE of +0.05%. Regarding short-term risk, AVR is more volatile compared to VREX. This indicates higher risk in terms of short-term price fluctuations for AVR.Check VREX's competition here
AdaptHealth Corp. (NASDAQ: AHCO)
AVR vs AHCO Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, AHCO has a market cap of 775.5M. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while AHCO trades at $5.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas AHCO's P/E ratio is 11.63. In terms of profitability, AVR's ROE is -0.78%, compared to AHCO's ROE of -0.15%. Regarding short-term risk, AVR is less volatile compared to AHCO. This indicates lower risk in terms of short-term price fluctuations for AVR.Check AHCO's competition here
SS Innovations International, Inc. (NASDAQ: SSII)
AVR vs SSII Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, SSII has a market cap of 766.5M. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while SSII trades at $3.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas SSII's P/E ratio is -74.70. In terms of profitability, AVR's ROE is -0.78%, compared to SSII's ROE of -0.27%. Regarding short-term risk, AVR is less volatile compared to SSII. This indicates lower risk in terms of short-term price fluctuations for AVR.Check SSII's competition here
BrainsWay Ltd. (NASDAQ: BWAY)
AVR vs BWAY Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, BWAY has a market cap of 646M. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while BWAY trades at $16.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas BWAY's P/E ratio is 41.84. In terms of profitability, AVR's ROE is -0.78%, compared to BWAY's ROE of +0.12%. Regarding short-term risk, AVR is less volatile compared to BWAY. This indicates lower risk in terms of short-term price fluctuations for AVR.Check BWAY's competition here
OrthoPediatrics Corp. (NASDAQ: KIDS)
AVR vs KIDS Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, KIDS has a market cap of 642.4M. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while KIDS trades at $25.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas KIDS's P/E ratio is -21.19. In terms of profitability, AVR's ROE is -0.78%, compared to KIDS's ROE of -0.12%. Regarding short-term risk, AVR is more volatile compared to KIDS. This indicates higher risk in terms of short-term price fluctuations for AVR.Check KIDS's competition here
Cytek Biosciences, Inc. (NASDAQ: CTKB)
AVR vs CTKB Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, CTKB has a market cap of 631.5M. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while CTKB trades at $4.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas CTKB's P/E ratio is -25.91. In terms of profitability, AVR's ROE is -0.78%, compared to CTKB's ROE of -0.24%. Regarding short-term risk, AVR is less volatile compared to CTKB. This indicates lower risk in terms of short-term price fluctuations for AVR.Check CTKB's competition here
Surmodics, Inc. (NASDAQ: SRDX)
AVR vs SRDX Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, SRDX has a market cap of 614.5M. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while SRDX trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas SRDX's P/E ratio is -34.66. In terms of profitability, AVR's ROE is -0.78%, compared to SRDX's ROE of -0.10%. Regarding short-term risk, AVR is more volatile compared to SRDX. This indicates higher risk in terms of short-term price fluctuations for AVR.Check SRDX's competition here
Delcath Systems, Inc. (NASDAQ: DCTH)
AVR vs DCTH Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, DCTH has a market cap of 599.3M. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while DCTH trades at $17.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas DCTH's P/E ratio is 1736.00. In terms of profitability, AVR's ROE is -0.78%, compared to DCTH's ROE of +0.00%. Regarding short-term risk, AVR is more volatile compared to DCTH. This indicates higher risk in terms of short-term price fluctuations for AVR.Check DCTH's competition here
Apollo Endosurgery, Inc. (NASDAQ: APEN)
AVR vs APEN Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while APEN trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas APEN's P/E ratio is -9.43. In terms of profitability, AVR's ROE is -0.78%, compared to APEN's ROE of -0.85%. Regarding short-term risk, AVR is more volatile compared to APEN. This indicates higher risk in terms of short-term price fluctuations for AVR.Check APEN's competition here
Cerus Corporation (NASDAQ: CERS)
AVR vs CERS Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, CERS has a market cap of 572.3M. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while CERS trades at $2.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas CERS's P/E ratio is -56.69. In terms of profitability, AVR's ROE is -0.78%, compared to CERS's ROE of -0.10%. Regarding short-term risk, AVR is less volatile compared to CERS. This indicates lower risk in terms of short-term price fluctuations for AVR.Check CERS's competition here
ZimVie Inc. (NASDAQ: ZIMV)
AVR vs ZIMV Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, ZIMV has a market cap of 535.6M. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while ZIMV trades at $18.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas ZIMV's P/E ratio is -27.52. In terms of profitability, AVR's ROE is -0.78%, compared to ZIMV's ROE of -0.01%. Regarding short-term risk, AVR is more volatile compared to ZIMV. This indicates higher risk in terms of short-term price fluctuations for AVR.Check ZIMV's competition here
Tactile Systems Technology, Inc. (NASDAQ: TCMD)
AVR vs TCMD Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, TCMD has a market cap of 534.8M. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while TCMD trades at $23.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas TCMD's P/E ratio is 26.94. In terms of profitability, AVR's ROE is -0.78%, compared to TCMD's ROE of +0.11%. Regarding short-term risk, AVR is less volatile compared to TCMD. This indicates lower risk in terms of short-term price fluctuations for AVR.Check TCMD's competition here
NeuroPace, Inc. (NASDAQ: NPCE)
AVR vs NPCE Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, NPCE has a market cap of 494.7M. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while NPCE trades at $14.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas NPCE's P/E ratio is -22.32. In terms of profitability, AVR's ROE is -0.78%, compared to NPCE's ROE of -1.20%. Regarding short-term risk, AVR is less volatile compared to NPCE. This indicates lower risk in terms of short-term price fluctuations for AVR.Check NPCE's competition here
ClearPoint Neuro, Inc. (NASDAQ: CLPT)
AVR vs CLPT Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, CLPT has a market cap of 462.4M. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while CLPT trades at $15.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas CLPT's P/E ratio is -13.07. In terms of profitability, AVR's ROE is -0.78%, compared to CLPT's ROE of -1.88%. Regarding short-term risk, AVR is more volatile compared to CLPT. This indicates higher risk in terms of short-term price fluctuations for AVR.Check CLPT's competition here
Sight Sciences, Inc. (NASDAQ: SGHT)
AVR vs SGHT Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, SGHT has a market cap of 452.7M. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while SGHT trades at $8.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas SGHT's P/E ratio is -14.86. In terms of profitability, AVR's ROE is -0.78%, compared to SGHT's ROE of -0.51%. Regarding short-term risk, AVR is less volatile compared to SGHT. This indicates lower risk in terms of short-term price fluctuations for AVR.Check SGHT's competition here
Orthofix Medical Inc. (NASDAQ: OFIX)
AVR vs OFIX Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, OFIX has a market cap of 411.5M. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while OFIX trades at $10.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas OFIX's P/E ratio is -13.30. In terms of profitability, AVR's ROE is -0.78%, compared to OFIX's ROE of -0.14%. Regarding short-term risk, AVR is less volatile compared to OFIX. This indicates lower risk in terms of short-term price fluctuations for AVR.Check OFIX's competition here
Carlsmed, Inc. (NASDAQ: CARL)
AVR vs CARL Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, CARL has a market cap of 380.3M. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while CARL trades at $13.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas CARL's P/E ratio is -9.78. In terms of profitability, AVR's ROE is -0.78%, compared to CARL's ROE of -0.38%. Regarding short-term risk, AVR is more volatile compared to CARL. This indicates higher risk in terms of short-term price fluctuations for AVR.Check CARL's competition here
Pacific Biosciences of California, Inc. (NASDAQ: PACB)
AVR vs PACB Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, PACB has a market cap of 357.2M. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while PACB trades at $1.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas PACB's P/E ratio is -2.80. In terms of profitability, AVR's ROE is -0.78%, compared to PACB's ROE of -49.62%. Regarding short-term risk, AVR is less volatile compared to PACB. This indicates lower risk in terms of short-term price fluctuations for AVR.Check PACB's competition here
Picard Medical, Inc. (AMEX: PMI)
AVR vs PMI Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, PMI has a market cap of 354.8M. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while PMI trades at $3.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas PMI's P/E ratio is -2.88. In terms of profitability, AVR's ROE is -0.78%, compared to PMI's ROE of +4.99%. Regarding short-term risk, AVR is less volatile compared to PMI. This indicates lower risk in terms of short-term price fluctuations for AVR.Check PMI's competition here
Perspective Therapeutics, Inc. (AMEX: CATX)
AVR vs CATX Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, CATX has a market cap of 352.4M. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while CATX trades at $3.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas CATX's P/E ratio is -2.19. In terms of profitability, AVR's ROE is -0.78%, compared to CATX's ROE of -0.42%. Regarding short-term risk, AVR is less volatile compared to CATX. This indicates lower risk in terms of short-term price fluctuations for AVR.Check CATX's competition here
Electromed, Inc. (AMEX: ELMD)
AVR vs ELMD Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, ELMD has a market cap of 351.1M. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while ELMD trades at $42.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas ELMD's P/E ratio is 36.24. In terms of profitability, AVR's ROE is -0.78%, compared to ELMD's ROE of +0.22%. Regarding short-term risk, AVR is similarly volatile compared to ELMD. This indicates similar risk in terms of short-term price fluctuations for AVR.Check ELMD's competition here
TriSalus Life Sciences, Inc. (NASDAQ: TLSI)
AVR vs TLSI Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, TLSI has a market cap of 346.7M. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while TLSI trades at $5.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas TLSI's P/E ratio is -3.35. In terms of profitability, AVR's ROE is -0.78%, compared to TLSI's ROE of +2.74%. Regarding short-term risk, AVR is less volatile compared to TLSI. This indicates lower risk in terms of short-term price fluctuations for AVR.Check TLSI's competition here
CapsoVision, Inc. (NASDAQ: CV)
AVR vs CV Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, CV has a market cap of 339.3M. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while CV trades at $6.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas CV's P/E ratio is -2.72. In terms of profitability, AVR's ROE is -0.78%, compared to CV's ROE of +1.27%. Regarding short-term risk, AVR is less volatile compared to CV. This indicates lower risk in terms of short-term price fluctuations for AVR.Check CV's competition here
Senseonics Holdings, Inc. (NASDAQ: SENS)
AVR vs SENS Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, SENS has a market cap of 323.1M. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while SENS trades at $7.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas SENS's P/E ratio is -3.86. In terms of profitability, AVR's ROE is -0.78%, compared to SENS's ROE of -1.66%. Regarding short-term risk, AVR is less volatile compared to SENS. This indicates lower risk in terms of short-term price fluctuations for AVR.Check SENS's competition here
Semler Scientific, Inc. (NASDAQ: SMLR)
AVR vs SMLR Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, SMLR has a market cap of 310.7M. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while SMLR trades at $20.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas SMLR's P/E ratio is 3.92. In terms of profitability, AVR's ROE is -0.78%, compared to SMLR's ROE of +0.06%. Regarding short-term risk, AVR is more volatile compared to SMLR. This indicates higher risk in terms of short-term price fluctuations for AVR.Check SMLR's competition here
Treace Medical Concepts, Inc. (NASDAQ: TMCI)
AVR vs TMCI Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, TMCI has a market cap of 292.6M. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while TMCI trades at $4.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas TMCI's P/E ratio is -4.80. In terms of profitability, AVR's ROE is -0.78%, compared to TMCI's ROE of -0.74%. Regarding short-term risk, AVR is less volatile compared to TMCI. This indicates lower risk in terms of short-term price fluctuations for AVR.Check TMCI's competition here
RxSight, Inc. (NASDAQ: RXST)
AVR vs RXST Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, RXST has a market cap of 290.2M. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while RXST trades at $7.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas RXST's P/E ratio is -7.54. In terms of profitability, AVR's ROE is -0.78%, compared to RXST's ROE of -0.17%. Regarding short-term risk, AVR is less volatile compared to RXST. This indicates lower risk in terms of short-term price fluctuations for AVR.Check RXST's competition here
Anika Therapeutics, Inc. (NASDAQ: ANIK)
AVR vs ANIK Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, ANIK has a market cap of 283.3M. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while ANIK trades at $21.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas ANIK's P/E ratio is 43.20. In terms of profitability, AVR's ROE is -0.78%, compared to ANIK's ROE of -0.03%. Regarding short-term risk, AVR is less volatile compared to ANIK. This indicates lower risk in terms of short-term price fluctuations for AVR.Check ANIK's competition here
Monogram Orthopaedics, Inc. (NASDAQ: MGRM)
AVR vs MGRM Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, MGRM has a market cap of 243.8M. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while MGRM trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas MGRM's P/E ratio is -12.00. In terms of profitability, AVR's ROE is -0.78%, compared to MGRM's ROE of -0.85%. Regarding short-term risk, AVR is more volatile compared to MGRM. This indicates higher risk in terms of short-term price fluctuations for AVR.Check MGRM's competition here
Profound Medical Corp. (NASDAQ: PROF)
AVR vs PROF Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, PROF has a market cap of 242.4M. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while PROF trades at $6.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas PROF's P/E ratio is -5.38. In terms of profitability, AVR's ROE is -0.78%, compared to PROF's ROE of -0.56%. Regarding short-term risk, AVR is less volatile compared to PROF. This indicates lower risk in terms of short-term price fluctuations for AVR.Check PROF's competition here
Nevro Corp. (NYSE: NVRO)
AVR vs NVRO Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while NVRO trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas NVRO's P/E ratio is -1.91. In terms of profitability, AVR's ROE is -0.78%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, AVR is more volatile compared to NVRO. This indicates higher risk in terms of short-term price fluctuations for AVR.Check NVRO's competition here
Neuronetics, Inc. (NASDAQ: STIM)
AVR vs STIM Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, STIM has a market cap of 210.9M. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while STIM trades at $3.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas STIM's P/E ratio is -5.61. In terms of profitability, AVR's ROE is -0.78%, compared to STIM's ROE of -1.51%. Regarding short-term risk, AVR is less volatile compared to STIM. This indicates lower risk in terms of short-term price fluctuations for AVR.Check STIM's competition here
Avita Medical Inc. (NASDAQ: RCEL)
AVR vs RCEL Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, RCEL has a market cap of 199M. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while RCEL trades at $8.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas RCEL's P/E ratio is -5.10. In terms of profitability, AVR's ROE is -0.78%, compared to RCEL's ROE of +2.32%. Regarding short-term risk, AVR is less volatile compared to RCEL. This indicates lower risk in terms of short-term price fluctuations for AVR.Check RCEL's competition here
BioSig Technologies, Inc. (NASDAQ: BSGM)
AVR vs BSGM Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, BSGM has a market cap of 191.1M. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while BSGM trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas BSGM's P/E ratio is -5.81. In terms of profitability, AVR's ROE is -0.78%, compared to BSGM's ROE of +15.26%. Regarding short-term risk, AVR is less volatile compared to BSGM. This indicates lower risk in terms of short-term price fluctuations for AVR.Check BSGM's competition here
Lucid Diagnostics Inc. (NASDAQ: LUCD)
AVR vs LUCD Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, LUCD has a market cap of 184.1M. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while LUCD trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas LUCD's P/E ratio is -2.61. In terms of profitability, AVR's ROE is -0.78%, compared to LUCD's ROE of -0.02%. Regarding short-term risk, AVR is less volatile compared to LUCD. This indicates lower risk in terms of short-term price fluctuations for AVR.Check LUCD's competition here
Xylo Technologies Ltd. (NASDAQ: MDGS)
AVR vs MDGS Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, MDGS has a market cap of 178.9M. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while MDGS trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas MDGS's P/E ratio is -0.27. In terms of profitability, AVR's ROE is -0.78%, compared to MDGS's ROE of -0.51%. Regarding short-term risk, AVR is less volatile compared to MDGS. This indicates lower risk in terms of short-term price fluctuations for AVR.Check MDGS's competition here
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL)
AVR vs FOCL Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, FOCL has a market cap of 178M. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while FOCL trades at $4.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas FOCL's P/E ratio is -5.80. In terms of profitability, AVR's ROE is -0.78%, compared to FOCL's ROE of -1.38%. Regarding short-term risk, AVR is less volatile compared to FOCL. This indicates lower risk in terms of short-term price fluctuations for AVR.Check FOCL's competition here
Quipt Home Medical Corp. (NASDAQ: QIPT)
AVR vs QIPT Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, QIPT has a market cap of 162.3M. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while QIPT trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas QIPT's P/E ratio is -15.87. In terms of profitability, AVR's ROE is -0.78%, compared to QIPT's ROE of -0.10%. Regarding short-term risk, AVR is more volatile compared to QIPT. This indicates higher risk in terms of short-term price fluctuations for AVR.Check QIPT's competition here
Inogen, Inc. (NASDAQ: INGN)
AVR vs INGN Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, INGN has a market cap of 157.3M. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while INGN trades at $5.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas INGN's P/E ratio is -6.38. In terms of profitability, AVR's ROE is -0.78%, compared to INGN's ROE of -0.13%. Regarding short-term risk, AVR is more volatile compared to INGN. This indicates higher risk in terms of short-term price fluctuations for AVR.Check INGN's competition here
Quanterix Corporation (NASDAQ: QTRX)
AVR vs QTRX Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, QTRX has a market cap of 134.7M. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while QTRX trades at $2.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas QTRX's P/E ratio is -1.79. In terms of profitability, AVR's ROE is -0.78%, compared to QTRX's ROE of -0.44%. Regarding short-term risk, AVR is less volatile compared to QTRX. This indicates lower risk in terms of short-term price fluctuations for AVR.Check QTRX's competition here
Owlet, Inc. (NYSE: OWLT)
AVR vs OWLT Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, OWLT has a market cap of 114.5M. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while OWLT trades at $6.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas OWLT's P/E ratio is -45.21. In terms of profitability, AVR's ROE is -0.78%, compared to OWLT's ROE of -0.50%. Regarding short-term risk, AVR is less volatile compared to OWLT. This indicates lower risk in terms of short-term price fluctuations for AVR.Check OWLT's competition here
iCAD, Inc. (NASDAQ: ICAD)
AVR vs ICAD Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, ICAD has a market cap of 106.3M. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while ICAD trades at $3.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas ICAD's P/E ratio is -20.37. In terms of profitability, AVR's ROE is -0.78%, compared to ICAD's ROE of -0.18%. Regarding short-term risk, AVR is more volatile compared to ICAD. This indicates higher risk in terms of short-term price fluctuations for AVR.Check ICAD's competition here
Solana Company (NASDAQ: HSDT)
AVR vs HSDT Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, HSDT has a market cap of 105.1M. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while HSDT trades at $1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas HSDT's P/E ratio is -0.02. In terms of profitability, AVR's ROE is -0.78%, compared to HSDT's ROE of -1.55%. Regarding short-term risk, AVR is less volatile compared to HSDT. This indicates lower risk in terms of short-term price fluctuations for AVR.Check HSDT's competition here
Hancock Jaffe Laboratories (NASDAQ: HJLI)
AVR vs HJLI Comparison August 2026
Anteris Technologies Global Corp. (NASDAQ: AVR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVR stands at 868.3M. In comparison, HJLI has a market cap of 98.3M. Regarding current trading prices, AVR is priced at $8.93 on the NASDAQ, while HJLI trades at $10.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVR currently has a P/E ratio of -4.00, whereas HJLI's P/E ratio is N/A. In terms of profitability, AVR's ROE is -0.78%, compared to HJLI's ROE of -0.62%. Regarding short-term risk, AVR is less volatile compared to HJLI. This indicates lower risk in terms of short-term price fluctuations for AVR.Check HJLI's competition here